[The importance of the ketamine in depressive disorders]. / Znaczenie ketaminy w leczeniu zaburzen depresyjnych.
Pol Merkur Lekarski
; 45(267): 134-136, 2018 Sep 21.
Article
em Pl
| MEDLINE
| ID: mdl-30240385
ABSTRACT
Depressive disorders are the most common disease entities in psychiatry. Slightly more than 50% of patients diagnosed with major depressive disorder (MDD) were treated using available antidepressants have shown the complete remission, and over 1/3 of patients have not responded to conventional treatment presenting treatment-resistant depression (TRD). Possible treatment of this type of disorder is pharmacotherapy, which in some cases turns out to be ineffective. Scientists studying this problem suggest using ketamine - a drug known for being used in anaesthesiology and intensive therapy.
Palavras-chave
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Transtorno Depressivo Maior
/
Ketamina
Limite:
Humans
Idioma:
Pl
Ano de publicação:
2018
Tipo de documento:
Article